Also the question of how to handle clinical trials when the treatment is by design n=1. This world is getting less murky but as far as I know isn't yet 100% str

Also the question of how to handle clinical trials when the treatment is by design n=1. This world is getting less murky but as far as I know isn't yet 100% straightforward.